Proteinuri (se pkt 4. 4) Proteinuri er blevet set hos mellem 0, 7% og 38% af patienterne, som fik Avastin i kliniske studier.
In clinical trials, proteinuria has been reported within the range of 0.7% to 38% of patients receiving Avastin.